Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Apr 5, 2024
Date Accepted: Jul 17, 2024

The final, peer-reviewed published version of this preprint can be found here:

Mpox Discourse on Twitter by Sexual Minority Men and Gender-Diverse Individuals: Infodemiological Study Using BERTopic

Wang Y, O’Connor K, Flores I, Berdahl CT, Urbanowicz RJ, Stevens R, Bauermeister JA, Gonzalez-Hernandez G

Mpox Discourse on Twitter by Sexual Minority Men and Gender-Diverse Individuals: Infodemiological Study Using BERTopic

JMIR Public Health Surveill 2024;10:e59193

DOI: 10.2196/59193

PMID: 39137013

PMCID: 11350314

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Health activism, vaccine, and mpox discourse: BERTopic based mixed-method analyses of tweets from sexual minority men and gender diverse (SMMGD) individuals in the U.S.

  • Yunwen Wang; 
  • Karen O’Connor; 
  • Ivan Flores; 
  • Carl T. Berdahl; 
  • Ryan J. Urbanowicz; 
  • Robin Stevens; 
  • José A. Bauermeister; 
  • Graciela Gonzalez-Hernandez

ABSTRACT

Background:

The recent mpox outbreak has resulted in 31,010 cases and 55 deaths in the U.S., and 91,417 cases worldwide from May 2022 to October 2023. Like other disease outbreaks (e.g., HIV) with perceived community associations, mpox is at risk of causing stigma, exacerbating homophobia, and potentially hindering healthcare access and social equity.

Objective:

To synthesize discussions among sexual minority men and gender diverse (SMMGD) individuals on mpox, given limited representation of SMMGD voices in existing mpox literature.

Methods:

BERTopic (a topic modeling technique) was employed with human validations to analyze mpox-related tweets (n = 8,688; October 2020—September 2022) from 2,326 self-identified SMMGD individuals in the U.S.; followed by content analysis and geographic analysis.

Results:

BERTopic identified 11 topics: health activism (29.81%); mpox vaccination (25.81%) and adverse events (0.98%); sarcasm, jokes, emotional expressions (14.04%); COVID-19 and mpox (7.32%); government/public health response (6.12%); mpox symptoms (2.74%); case reports (2.21%); puns on the virus’ naming (i.e., monkeypox; 0.86%); media publicity (0.68%); mpox in children (0.67%). Mpox health activism negatively correlated with LGB social climate index at U.S. state level, ρ = -.322, P = .031.

Conclusions:

SMMGD discussions on mpox encompassed utilitarian (e.g., vaccine access, case reports, mpox symptoms) and emotionally-charged themes—advocating against homophobia, misinformation, and stigma. Mpox health activism was more prevalent in states with lower LGB social acceptance. Findings illuminate SMMGD engagement with mpox discourse, underscoring the need for more inclusive health communication strategies in infectious disease outbreaks to control associated stigma. Clinical Trial: NA


 Citation

Please cite as:

Wang Y, O’Connor K, Flores I, Berdahl CT, Urbanowicz RJ, Stevens R, Bauermeister JA, Gonzalez-Hernandez G

Mpox Discourse on Twitter by Sexual Minority Men and Gender-Diverse Individuals: Infodemiological Study Using BERTopic

JMIR Public Health Surveill 2024;10:e59193

DOI: 10.2196/59193

PMID: 39137013

PMCID: 11350314

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.